• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STRYKER NEUROVASCULAR CORK TARGET 360 ULTRA 2MM X 4CM; DEVICE, NEUROVASCULAR EMBOLIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STRYKER NEUROVASCULAR CORK TARGET 360 ULTRA 2MM X 4CM; DEVICE, NEUROVASCULAR EMBOLIZATION Back to Search Results
Model Number M0035422040
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Headache (1880)
Date of Event 06/03/2016
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
This is 2 of 12 emdr filed for this event (10 coils and 2 microcatheters).The subject coil remains implanted.
 
Event or Problem Description
It was reported that during the stent assisted coil embolization of the un-ruptured aneurysm, the patient experienced headache which resolved without residual effect the next day.Post procedure the patient was assessed having a mrs of 0 and the aneurysm occlusion status was assessed as 2 - residual neck/dog ear defined as the persistence of any portion of the original defect of the arterial wall.The study facility assessed the headache as being possibly related to the stent and procedure; however, unknown to the implanted coils (subject device) and microcatheters.During patient follow up visits at 2 and 6 months post the index procedure, the patient was assessed having a mrs of 0.No further information is available.
 
Additional Manufacturer Narrative
The device history record (dhr) review confirmed that the device met all material, assembly and performance specifications.The subject device remains implanted; therefore, physical as well as a functional evaluation could not be performed.However, headache is a known risk associated with endovascular procedures and is noted as such in the device direction for use (dfu).Therefore, an assignable cause of anticipated procedural complications was assigned to this event.
 
Event or Problem Description
It was reported that during the stent assisted coil embolization of the un-ruptured aneurysm, the patient experienced headache which resolved without residual effect the next day.Post procedure the patient was assessed having a mrs of 0 and the aneurysm occlusion status was assessed as 2 - residual neck/dog ear defined as the persistence of any portion of the original defect of the arterial wall.The study facility assessed the headache as being possibly related to the stent and procedure; however, unknown to the implanted coils (subject device) and microcatheters.During patient follow up visits at 2 and 6 months post the index procedure, the patient was assessed having a mrs of 0.No further information is available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TARGET 360 ULTRA 2MM X 4CM
Common Device Name
DEVICE, NEUROVASCULAR EMBOLIZATION
Manufacturer (Section D)
STRYKER NEUROVASCULAR CORK
ida industrial estate
model farm road
cork NA
MDR Report Key6939378
Report Number3008881809-2017-00426
Device Sequence Number891989
Product Code HCG
UDI-Device Identifier04546540675842
UDI-Public(01)04546540675842(17)180930(10)18600097
Combination Product (Y/N)N
Initial Reporter StatePA
Initial Reporter CountryUS
PMA/510(K) Number
K102672
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2016
Reporter Type Manufacturer
Report Source study
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 12/04/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date09/30/2018
Device Model NumberM0035422040
Device Catalogue NumberM0035422040
Device Lot Number18600097
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 09/13/2017
Supplement Date Received by Manufacturer11/07/2017
Initial Report FDA Received Date10/10/2017
Supplement Report FDA Received Date12/04/2017
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age55 YR
-
-